Orion S.A.
OEC NYSE Miscellaneous Chemical Products Financials FY2017βFY2025
What Orion S.A. does
No business description yet.
- Legal name
- Orion S.A.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 17, 2026
- Accession Β· CIK
- 0001628280-26-008601
0001609804
Revenue and margins
Orion S.A. had $1.8B of revenue in fiscal 2025, down 3.8% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $54.8M in fiscal 2025, 3.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Orion S.A. returned $29.5M to shareholders in fiscal 2025, 54% of free cash flow. The diluted share count fell 3.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably Orion S.A. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $65.7M | $60.8M | $37.5M | $44.2M | $60.7M |
| Debt incl. finance leases | $997M | $1.3B | $1.0B | $1.2B | $1.4B |
| Net debt / EBITDA | 2.8x | 3.9x | 3.2x | 5.3x | 8.1x |
| Debt / equity | 2.9x | 2.5x | 2.0x | 2.4x | 3.3x |
| Interest coverage | 6.0x | 4.9x | 4.0x | β | β |
| Current ratio | 1.5x | 1.4x | 1.5x | 1.2x | 1.0x |
| Quick ratio | 1.0x | 0.9x | 0.8x | 0.6x | 0.6x |
| Total assets | $1.6B | $1.9B | $1.8B | $1.9B | $1.9B |
| Total liabilities | $1.3B | $1.4B | $1.4B | $1.4B | $1.5B |
| Shareholders' equity | $320M | $459M | $479M | $475M | $385M |
| Net debt (β = net cash) | $931M | $1.2B | $1.0B | $1.2B | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 7 | 4 / 9 | 3 / 9 | 7 / 9 | 3 / 9 | 8 / 9 | 4 / 9 | 3 / 9 |
| Accruals ratio | β7.1% | β0.1% | β11.4% | β8.1% | β0.7% | 1.4% | β13.0% | β4.4% | β15.2% |
| Altman Z'' | β | 2.60 | 2.33 | 1.54 | 2.50 | 2.37 | 2.60 | 1.88 | 1.08 |
9 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $1.3B | $1.6B | $1.5B | $1.1B | $1.5B | $2.0B | $1.9B | $1.9B | $1.8B |
| Gross profit | $378M | $430M | $390M | $292M | $387M | $449M | $451M | $429M | $360M |
| Research and development | $18.2M | $20.3M | $19.9M | $20.2M | $22.0M | $21.7M | $24.5M | $27.1M | $27.5M |
| Operating income | $138M | $196M | $147M | $74.4M | $229M | $197M | $205M | $103M | $27.5M |
| Interest expense | $44.1M | $28.6M | $27.6M | $38.7M | $38.0M | $39.9M | $50.9M | β | β |
| Pretax income | $84.6M | $168M | $120M | $26.3M | $186M | $158M | $164M | $53.9M | β$34.3M |
| Income tax | $19.7M | $46.9M | $33.3M | $8.1M | $51.7M | $51.5M | $60.3M | $9.7M | $35.8M |
| Net income | $64.9M | $121M | $86.9M | $18.2M | $135M | $106M | $104M | $44.2M | β$70.1M |
| Diluted EPS | $1.07 | $1.99 | $1.42 | $0.30 | $2.21 | $1.73 | $1.73 | $0.76 | β$1.24 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B |
| Cash flow | |||||||||
| Cash from operations | $148M | $122M | $232M | $125M | $145M | $81.0M | $346M | $125M | $216M |
| Capital expenditure | $99.0M | $111M | $159M | $139M | $215M | $233M | $173M | $207M | $161M |
| Free cash flow | $48.8M | $10.9M | $72.8M | β$13.5M | β$69.5M | β$152M | $173M | β$81.4M | $54.8M |
| Depreciation and amortization | $98.4M | $98.2M | $96.7M | $96.6M | $104M | $106M | $113M | $125M | $132M |
| Stock-based compensation | $8.8M | $13.9M | $9.4M | $4.4M | $5.2M | $7.7M | $15.4M | $15.3M | $13.6M |
| Acquisitions | $0.0M | $36.6M | $0.0M | $0.0M | β | β | β | β | β |
| Share buybacks | $0.0M | $4.9M | $0.0M | $0.0M | $0.0M | $4.3M | $65.6M | $26.6M | $24.8M |
| Dividends paid | $45.7M | $47.7M | $48.1M | $12.0M | $0.0M | $5.0M | $4.9M | $4.8M | $4.7M |
| Dividends and buybacks | $45.7M | $52.6M | $48.1M | $12.0M | $0.0M | $9.3M | $70.5M | $31.4M | $29.5M |
| Balance sheet | |||||||||
| Cash and short-term investments | $72.3M | $57.0M | $63.7M | $64.9M | $65.7M | $60.8M | $37.5M | $44.2M | $60.7M |
| Total debt | β | $719M | $696M | $814M | $932M | $1.2B | $949M | $1.2B | $1.3B |
| Finance lease liabilities | β | β | β | $60.4M | $64.7M | $79.7M | $91.4M | $85.6M | $89.0M |
| Current assets | β | $575M | $508M | $501M | $665M | $779M | $646M | $613M | $644M |
| Current liabilities | β | $320M | $285M | $325M | $449M | $553M | $440M | $517M | $626M |
| Inventory | β | $184M | $165M | $142M | $230M | $278M | $287M | $290M | $277M |
| Property and equipment, net | β | $484M | β | β | β | β | β | β | β |
| Goodwill | $58.2M | $55.5M | $77.4M | $84.5M | $78.0M | $73.4M | $76.1M | $71.5M | $0.0M |
| Intangible assets | β | $95.2M | $50.6M | $46.8M | $36.3M | $27.8M | $25.5M | $18.5M | $14.2M |
| Total assets | $1.2B | $1.3B | $1.3B | $1.4B | $1.6B | $1.9B | $1.8B | $1.9B | $1.9B |
| Total liabilities | β | $1.1B | $1.1B | $1.2B | $1.3B | $1.4B | $1.4B | $1.4B | $1.5B |
| Shareholders' equity | $95.3M | $159M | $186M | $181M | $320M | $459M | $479M | $475M | $385M |
| Margins | |||||||||
| Gross margin | 28.4% | 27.2% | 26.4% | 25.7% | 25.0% | 22.1% | 23.8% | 22.8% | 19.9% |
| Operating margin | 10.4% | 12.4% | 10.0% | 6.5% | 14.8% | 9.7% | 10.8% | 5.5% | 1.5% |
| EBITDA margin | 17.8% | 18.7% | 16.5% | 15.0% | 21.5% | 14.9% | 16.8% | 12.1% | 8.8% |
| Net margin | 4.9% | 7.7% | 5.9% | 1.6% | 8.7% | 5.2% | 5.5% | 2.4% | β3.9% |
| FCF margin | 3.7% | 0.7% | 4.9% | β1.2% | β4.5% | β7.5% | 9.1% | β4.3% | 3.0% |
| Returns | |||||||||
| Return on capital | β | 17.2% | 13.0% | 5.5% | 13.9% | 8.5% | 9.6% | 5.3% | 1.4% |
| Return on capital employed | β | 20.6% | 15.1% | 7.0% | 19.3% | 14.8% | 14.7% | 7.7% | 2.1% |
| Return on equity | 68.1% | 95.4% | 50.4% | 9.9% | 53.8% | 27.3% | 22.1% | 9.3% | β16.3% |
| Return on assets | 5.6% | 10.0% | 6.9% | 1.4% | 8.9% | 6.0% | 5.6% | 2.4% | β3.7% |
| Return on tangible equity | 174.7% | 1,496.0% | 149.8% | 36.6% | 65.6% | 29.6% | 27.5% | 11.5% | β18.9% |
| Growth | |||||||||
| Revenue growth | β | 18.8% | β6.5% | β23.0% | 36.1% | 31.3% | β6.7% | β0.9% | β3.8% |
| Net income growth | β | 87.0% | β28.4% | β79.1% | 640.1% | β21.2% | β2.5% | β57.3% | β258.6% |
| EPS growth | β | 86.0% | β28.6% | β78.9% | 636.7% | β21.7% | 0.0% | β56.1% | β263.2% |
| FCF growth | β | β77.6% | 566.2% | β118.5% | β | β | β | β147.0% | β |
| Share count change | β | 0.6% | 0.4% | 0.2% | β0.7% | 0.7% | β2.3% | β2.7% | β3.5% |
| Financial health | |||||||||
| Net debt / EBITDA | β | 2.2x | 2.6x | 4.7x | 2.8x | 3.9x | 3.2x | 5.3x | 8.1x |
| Debt / equity | β | 4.5x | 3.7x | 4.5x | 2.9x | 2.5x | 2.0x | 2.4x | 3.3x |
| Interest coverage | 3.1x | 6.9x | 5.3x | 1.9x | 6.0x | 4.9x | 4.0x | β | β |
| Current ratio | β | 1.8x | 1.8x | 1.5x | 1.5x | 1.4x | 1.5x | 1.2x | 1.0x |
| Quick ratio | β | 1.2x | 1.2x | 1.1x | 1.0x | 0.9x | 0.8x | 0.6x | 0.6x |
| Capital allocation | |||||||||
| Capex / revenue | 7.5% | 7.0% | 10.7% | 12.2% | 13.9% | 11.5% | 9.1% | 11.0% | 8.9% |
| Stock comp / revenue | 0.7% | 0.9% | 0.6% | 0.4% | 0.3% | 0.4% | 0.8% | 0.8% | 0.8% |
| Payouts / FCF | 93.7% | 481.3% | 66.1% | β | β | β | 40.7% | β | 53.8% |
| Quality scores | |||||||||
| Piotroski F-score | β | 5.0 | 4.0 | 3.0 | 7.0 | 3.0 | 8.0 | 4.0 | 3.0 |
| Altman Z'' | β | 2.6 | 2.3 | 1.5 | 2.5 | 2.4 | 2.6 | 1.9 | 1.1 |
| Accruals ratio | β7.1% | β0.1% | β11.4% | β8.1% | β0.7% | 1.4% | β13.0% | β4.4% | β15.2% |
Source: SEC EDGAR XBRL filings (CIK 0001609804). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.